For many patients access to a clinical trial can literally save their life. In speaking to The West Australian newspaper, Prof Chan Cheah told reporter Katie Hampson, when he trained in Melbourne and the U.S he had a range of trials he could put a patient on when they had exhausted all other options. These options kept his patients alive for longer, allowing them to create cherished memories with loved ones. Upon his return to Perth, patients in a similar situation had no other options and sadly passed away. Joining forces with the Snowdome Foundation, Prof Cheah set about creating Blood Cancer Research Western Australia (BCRWA) to offer blood cancer patients access to new treatments through clinical trials. Snowdome believes the partnership with BCRWA is a perfect match, we both want to ensure Australian blood cancer patients gain access to next-generation treatments so they can live longer, better lives.
Since 2018, thirty-six new clinical trials have been activated and an incredible 235 patients have gained access to a new treatment in Western Australia. With one new blood cancer patient being diagnosed every 31 minutes, the need for clinical trials has never been greater. However, the increased number of clinical trials on offer does come at a cost. Staff are needed to recruit, monitor and manage patients on trials. If you would like to help blood cancer patients in Western Australia access new treatments, please donate to Snowdome. You will be ‘making hope real’ for Western Australian blood cancer patients.
To read the full article in The West Australian please click the link below.